# Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.

> **NCT01958814** · PHASE2 · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 43 (actual)

## Conditions studied

- Chronic Respiratory Failure

## Interventions

- **DRUG:** Salbutamol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01958814
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01958814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01958814, "Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01958814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*